Finally, we investigated whether PCAT6 could affect the chemoresistance of CRC cell to 5‐FU‐based therapy through miR‐204‐mediated HMGA2/PI3K signaling pathway. This evidence concerns the gene PCAT6 and colorectal carcinoma.